Clinical Trials Browser

INDUSTRY × Neoplasms × Dasatinib × Clear all

NCT00099606 2011-04-19

Phase I (PH I) Mad Refractory Solid Tumor Study

Phase 1 Completed

Neoplasms

NCT00162214 2011-04-14

Study of Dasatinib in Patients With Advanced Solid Tumors

Phase 1 Terminated

Neoplasms

NCT00339144 2010-12-15

Study of Dasatinib (BMS-354825) in Patients With Solid Tumors

Phase 1 Completed

16 enrolled 29 charts

Neoplasms